Ozempic Users in Denmark Win Eye-Disease Payout
Insurance Journal - Nov 24, 2025
Four patients who developed a serious eye disease after using Novo Nordisk A/S’s blockbuster weight-loss drugs have been granted compensation in Denmark, the drugmaker’s home market. The claimants received a combined 800,000 kroner ($124,000), though that figure may rise if …...
Recommended Articles
Posted: Apr 09, 2026
A recent report by LexisNexis Risk Solutions found synthetic identity fraud is on the rise. Accordin...
Posted: Apr 09, 2026
Pine Walk, the specialist MGA platform of The Fidelis Partnership (TFP), has launched a new capital...
Posted: Apr 09, 2026
Israel bombed more targets in Lebanon on Thursday, putting the U.S.-Iran ceasefire into further jeop...